Description
AOD-9604 5MG
5MG | Laboratory Research Grade
AOD-9604 5mg (Anti-Obesity Drug) is a synthetic peptide fragment corresponding to the C-terminal end of the human growth hormone (amino acids 177-191). Within experimental protocols, this molecule is studied for its ability to stimulate lipolysis and inhibit lipogenesis without affecting blood glucose levels, as it lacks affinity for IGF-1 receptors. Explore our full range of Research Peptides.
⚠️ WARNING
This peptide must be reconstituted exclusively with 0.6% Acetic Acid and bacteriostatic water. The use of bacteriostatic water alone or saline may result in immediate precipitation (clumping) and product degradation.
AOD-9604 is known for its fragility and tendency to aggregate if reconstituted with standard bacteriostatic water. The use of 0.6% Acetic Acid maintains an acidic pH, ensuring perfect solubility and optimal molecular stability.
Product Technical Specifications
| Feature | Specification |
|---|---|
| Compound | AOD-9604 5MG |
| Sequence | Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Ph |
| Molecular Formula | C78H123N23O23S2 |
| Molecular Weight | 1815.08 g/mol |
| Analytical Purity | > 98% (HPLC Certified) |
| Format | Lyophilized Powder (Vacuum Stabilized) |
| Quantity | 5 mg per vial |
| Grade | Laboratory Research Grade |
Research Application Areas
- Lipolysis Mechanisms: Study of the stimulation of β3-adrenergic receptors and the increase of fat metabolism.
- Lipid Regulation: Research on the inhibition of pre-adipocyte transformation into mature adipocytes.
- Cartilage Repair: Analysis of the peptide’s impact on chondrogenic tissue regeneration in joint injury models.
- Safety Profile: Study of the absence of effects on insulin resistance compared to full-length growth hormone.
